# US 2010/0304988 A1 · Diagnostic of immune graft tolerance

> Agents: this data is available as JSON from the patentgrep API and MCP server — see https://patentgrep.com/llms.txt

- Number: US 2010/0304988 A1
- Document ID: US20100304988A1
- Status: Published application
- Kind: A1
- Application number: 12/599,234
- Filed: 2008-05-13
- Published: 2010-12-02
- Earliest claimed: 2007-05-10
- Inventors: Sophie Brouard; Christophe Braud; Magali Giral-Classe; Jean-Paul Soulillou; Marina Guillet
- Web page: https://patentgrep.com/patent/US20100304988A1

## CPC

- C12Q 1/6883: for diseases caused by alterations of genetic material
- C12Q 2600/158: Expression markers
- C12Q: MEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS (immunoassay G01N33/53); COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES

## Abstract

The present invention concerns a method for the in vitro diagnosis of a graft tolerant phenotype, comprising: determining from a grafted subject biological sample an expression profile comprising, or consisting of, 8 genes, and optionally at least one among 41 further genes, identified in the present invention as differentially expressed between graft tolerant subjects and subjects in chronic rejection, optionally measuring other parameters, and determining the presence or absence of a graft tolerant phenotype from said expression profile and optional other parameters. Said method may further comprise, if said subject is diagnosed as a graft non-tolerant subject, diagnosing from the expression profile if said subject is developing chronic rejection. The invention further concerns kits and oligonucleotide microarrays suitable to implement said method.

## Claims

### Claim 1

Method for the in vitro diagnosis of a graft tolerant or non-tolerant phenotype, comprising:
(a) determining from a grafted subject biological sample an expression profile comprising the 8 genes from Table 1,
(b) comparing the obtained expression profile with at least one reference expression profile, and
(c) determining the graft tolerant or graft non-tolerant phenotype from said comparison.

### Claim 2 (depends on 1)

The method of claim 1, wherein said expression profile further comprises at least one gene from Table 2.

### Claim 3 (depends on 2)

The method of claim 2, wherein said expression profile further comprises all the 41 genes from Table 2.

### Claim 4 (depends on 2)

The method of claim 2, wherein said expression profile further comprises the following 12 genes from Table 2: AKR1C1, BRRN1, C1S, CCL20, DEPDC1, GAGE, HBB, PLXNB1, RBM9, RGN, SPON1, and AKR1C2.

### Claim 5 (depends on 1)

The method of claim 1, wherein the obtained expression profile is compared to at least one reference expression tolerant and/or not tolerant profile in step (b).

### Claim 6 (depends on 1)

The method of claim 1, further comprising, if said subject is diagnosed as a graft non-tolerant subject, diagnosing from the expression profile if said subject is developing chronic rejection.

### Claim 7 (depends on 1)

The method of claim 1, wherein the expression profile is determined by measuring the amount of nucleic acid transcripts of said gene(s).

### Claim 8 (depends on 7)

The method of claim 7, wherein the expression profile is determined using quantitative PCR or an oligonucleotide microarray comprising 8 oligonucleotides specific for the 8 genes from Table 1.

### Claim 9 (depends on 1)

The method of claim 1, wherein the expression profile is determined using a genomic microarray or a proteic microarray.

### Claim 10 (depends on 1)

The method according to claim 1, wherein said biological sample is a blood sample.

### Claim 11 (depends on 1)

The method according to claim 1, wherein said subject is a kidney transplanted subject.

### Claim 12 (depends on 1)

The method according to claim 1, further comprising determining at least one additional parameter selected from standard biological parameters specific for said subject grafted organ type, phenotypic analyses of peripheral blood mononuclear cells (PBMC), and qualitative and/or quantitative analysis of PBMC immune repertoire.

### Claim 13 (depends on 1)

The method according to claim 1, further comprising between steps (b) and (c) the steps of:
(b1) obtaining from a grafted subject biological sample an expression profile comprising at least one gene from Table 3, and
(b2) comparing the obtained expression profile with at least one reference expression profile, and
wherein in step (c), the graft tolerant or graft non-tolerant phenotype is determined from the comparison of both step (b1) and step (b2).

### Claim 14

A kit for the in vitro diagnosis of a graft tolerant phenotype, comprising at least one reagent for the determination of an expression profile comprising the 8 genes from Table 1.

### Claim 15 (depends on 14)

The kit of claim 14, further comprising at least one reagent for determining at least one additional parameter selected from standard biological parameters specific for said subject grafted organ type, phenotypic analyses of peripheral blood mononuclear cells (PBMC), and qualitative and/or quantitative analysis of PBMC immune repertoire.

### Claim 16 (depends on 14)

The kit according to claim 14, further comprising at least one reagent for the determination of an expression profile comprising at least one gene from Table 3.

### Claim 17

A nucleic acid microarray comprising nucleic acids specific for the 8 genes from Table 1.

### Claim 18 (depends on 17)

The nucleic acid microarray according to claim 17 which is an oligonucleotide microarray.

### Claim 19 (depends on 14)

The kit according to claim 14, further comprising at least one reagent for the determination of an expression profile comprising at least one gene from Table 2.

### Claim 20 (depends on 17)

The nucleic acid microarray according to claim 17, further comprising nucleic acids specific for at least one nucleic acid for at least one gene from Table 2.
